|
Name |
5-Hydroxy-2,4-dimethylpentanoic acid, methyl ester
|
Molecular Formula | C8H16O3 | |
IUPAC Name* |
methyl 5-hydroxy-2,4-dimethylpentanoate
|
|
SMILES |
CC(CC(C)C(=O)OC)CO
|
|
InChI |
InChI=1S/C8H16O3/c1-6(5-9)4-7(2)8(10)11-3/h6-7,9H,4-5H2,1-3H3
|
|
InChIKey |
RGHYZUWIQIJUJU-UHFFFAOYSA-N
|
|
Synonyms |
5-Hydroxy-2,4-dimethylpentanoic acid, methyl ester; Methyl 5-hydroxy-2,4-dimethylpentanoate #
|
|
CAS | NA | |
PubChem CID | 560308 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 160.21 | ALogp: | 1.1 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 46.5 | Aromatic Rings: | 0 |
Heavy Atoms: | 11 | QED Weighted: | 0.629 |
Caco-2 Permeability: | -4.337 | MDCK Permeability: | 0.00024649 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.005 |
30% Bioavailability (F30%): | 0.033 |
Blood-Brain-Barrier Penetration (BBB): | 0.964 | Plasma Protein Binding (PPB): | 15.95% |
Volume Distribution (VD): | 0.904 | Fu: | 83.07% |
CYP1A2-inhibitor: | 0.266 | CYP1A2-substrate: | 0.598 |
CYP2C19-inhibitor: | 0.041 | CYP2C19-substrate: | 0.851 |
CYP2C9-inhibitor: | 0.008 | CYP2C9-substrate: | 0.263 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.336 |
CYP3A4-inhibitor: | 0.02 | CYP3A4-substrate: | 0.277 |
Clearance (CL): | 8.982 | Half-life (T1/2): | 0.829 |
hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.268 |
Drug-inuced Liver Injury (DILI): | 0.29 | AMES Toxicity: | 0.008 |
Rat Oral Acute Toxicity: | 0.027 | Maximum Recommended Daily Dose: | 0.017 |
Skin Sensitization: | 0.603 | Carcinogencity: | 0.043 |
Eye Corrosion: | 0.384 | Eye Irritation: | 0.962 |
Respiratory Toxicity: | 0.081 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000382 | 0.452 | D00WUF | 0.302 | ||||
ENC003040 | 0.388 | D0ZK8H | 0.263 | ||||
ENC001138 | 0.378 | D03XTC | 0.229 | ||||
ENC000819 | 0.366 | D04MWJ | 0.222 | ||||
ENC000307 | 0.344 | D07ZTO | 0.222 | ||||
ENC001474 | 0.344 | D0G8SQ | 0.222 | ||||
ENC000186 | 0.333 | D02UDJ | 0.216 | ||||
ENC001137 | 0.333 | D0R1QE | 0.214 | ||||
ENC000833 | 0.326 | D0U0OT | 0.214 | ||||
ENC000780 | 0.325 | D0KD1U | 0.212 |